About the company
Disinfection Company specializes in advanced, chemical- and heat-free disinfection solutions using innovative UV-C LED technology. Their modular platform offers sustainable, efficient disinfection of objects, air, and water, providing a safe and environmentally responsible alternative to traditional methods. Focused on the medical sector, the company delivers high-level disinfection with an emphasis on speed, reliability, and sustainability.
Why invest?
Disinfection Company is driven by a commitment to sustainability, offering a platform-based approach that facilitates rapid scaling and adaptability. With over 20 years of in-house expertise in UV-C LED technology, they are at the forefront of revolutionizing infection control. Innovative solutions provide sustainable, chemical- and heat-free high-level disinfection (HLD) for medical devices, enabling safe and efficient reprocessing at record speed. This advanced technology is supported by deep academic collaborations and two pending patents, ensuring to remain at the cutting edge of the industry. Robust partnerships with leading LED manufacturers further strengthen the competitive advantage. With a single-tier distribution model and the first distributors signing up, they are poised for significant growth and market penetration, making this a compelling opportunity for investors.
A unique investment opportunity
As the demand for sustainable and efficient disinfection solutions continues to rise, their company stands out as a leader in the medical sector, offering a sustainable alternative to traditional methods. This UV-C LED technology enables us to scale quickly and effectively while maintaining high safety standards. With DUOMED (BENELUX) already contractually committed to purchasing 50 devices contingent upon MDR certification, the growth trajectory is set to accelerate. This partnership, alongside with market-ready technology and proven experience, makes for an exceptional investment opportunity. By investing now, you can be part of a pioneering company that is transforming infection control in healthcare while ensuring long-term sustainability and profitability.
The investment
ZAPARAY has already secured €1.67M funding, partially from renowned investors, including: Dr. Prof. Kalmar, Dr. Ingels, A. Segers, J. Goossens, E. Vandenberghe, D. Cnudde, X. Deklerck, and P. Lamote. They also got support from Vlaio (+€500k granted) and received an initial loan from KBC.
Interested?
Get in touch to explore investment opportunities in this disinfectional-changing solution.
